Fonds Stratégique d'Investissement
VC Fund
Paris, France
Fonds Stratégique d'Investissement is a VC fund in Paris focused on Health Care and Biotechnology. Founded in 2008, Fonds Stratégique d'Investissement is a venture capital firm based in Paris, France.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Fonds Stratégique d'Investissement invests in
Stages Fonds Stratégique d'Investissement invests in
Countries Fonds Stratégique d'Investissement invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Biotechnology 2 (67%)
- Retail 1 (33%)
- Software 1 (33%)
- Enterprise 1 (33%)
Stage
- Series C 1 (33%)
- Series D 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bindstrongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management. | $53.8M / Series D / May 23, 2023 | ||
| ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment. | $54.9M / Series C / Jul 25, 2010 | ||
| Cylande SA provides enterprise resource planning software solutions for head offices, warehouses, and stores. It offers Cylande Commerce Spécialisé, a business solution for the personal goods market; and United Retail that offers solutions for trade movement from the sales centre, to the supply chain, from piloting points of sales to themanagement of the store environment, and front office and back office, as well as a global management for client relations. The company also provides Cylande Univeral Retail Suite, an ERP solution designed for optimizing merchandise management. In addition, it offers head office solutions, such as Cyrus REF and Cyrus CSM designed for the management of central purchasing operations in the mass-distribution sector; Cyrus PN that complements and enhances the vendor-relations management process; and Cyrus PR that effectuates competitor price statements and allows to lay down own pricing policy. Additionally, the company provides warehouse solutions, including Cyrus WMS, a module that offers management solutions for warehouse and logistics platform processes; and Cyrus WMS-V that provides voice-recognition for order and preparation processes. Further, it provides store solutions comprising Cyrus MAG designed for the management of store back-office functions in large and medium-sized retail stores, such as hypermarkets, supermarkets, and DIY superstores; Cyrus POS, a front office component of the mass market range; and Cyrus TT designed for the management of fresh produce in hypermarkets. Further more, it offers management solutions, such as Cyrus IC, a module that delivers centralized invoice control; and Cyrus BI, a module that consolidates and processes business data to produce reports on past, current, or future operations. Cylande SA serves large and average surface stores, corner stores, and boutiques. The company was founded in 1986 and is based in Roubaix, France. | $14.8M / Apr 30, 2010 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fonds Stratégique d'Investissement invest in?
Fonds Stratégique d'Investissement invests primarily in Health Care, Biotechnology and Retail startups, most often at Series C and Series D stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Fonds Stratégique d'Investissement last invest?
The most recent investment recorded for Fonds Stratégique d'Investissement closed in May 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
